Shibo Jiang
Shibo Jiang
Verified email at
Cited by
Cited by
The spike protein of SARS-CoV—a target for vaccine and therapeutic development
L Du, Y He, Y Zhou, S Liu, BJ Zheng, S Jiang
Nature Reviews Microbiology 7 (3), 226-236, 2009
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
W Tai, L He, X Zhang, J Pu, D Voronin, S Jiang, Y Zhou, L Du
Cellular & molecular immunology 17 (6), 613-620, 2020
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
X Tian, C Li, A Huang, S Xia, S Lu, Z Shi, L Lu, S Jiang, Z Yang, Y Wu, ...
Emerging microbes & infections 9 (1), 382-385, 2020
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways
Y Ding, LI He, Q Zhang, Z Huang, X Che, J Hou, H Wang, H Shen, L Qiu, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to …
S Xia, M Liu, C Wang, W Xu, Q Lan, S Feng, F Qi, L Bao, L Du, S Liu, ...
Cell research 30 (4), 343-355, 2020
Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses
S Jiang, C Hillyer, L Du
Trends in immunology 41 (5), 355-359, 2020
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
F Wu, A Wang, M Liu, Q Wang, J Chen, S Xia, Y Ling, Y Zhang, J Xun, ...
MedRxiv, 2020
HIV-1 inhibition by a peptide
S Jiang, K Lin, N Strick, AR Neurath
Nature 365 (6442), 113-113, 1993
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
S Xia, Y Zhu, M Liu, Q Lan, W Xu, Y Wu, T Ying, S Liu, Z Shi, S Jiang, L Lu
Cellular & molecular immunology 17 (7), 765-767, 2020
Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion …
S Liu, G Xiao, Y Chen, Y He, J Niu, CR Escalante, H Xiong, J Farmar, ...
The Lancet 363 (9413), 938-947, 2004
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
H Gu, Q Chen, G Yang, L He, H Fan, YQ Deng, Y Wang, Y Teng, Z Zhao, ...
Science 369 (6511), 1603-1607, 2020
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
L Lu, Q Liu, Y Zhu, KH Chan, L Qin, Y Li, Q Wang, JFW Chan, L Du, F Yu, ...
Nature communications 5 (1), 1-12, 2014
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
Y He, Y Zhou, S Liu, Z Kou, W Li, M Farzan, S Jiang
Biochemical and biophysical research communications 324 (2), 773-781, 2004
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
F Yu, L Du, DM Ojcius, C Pan, S Jiang
Microbes and infection 22 (2), 74-79, 2020
Expression of elevated levels of pro‐inflammatory cytokines in SARS‐CoV‐infected ACE2+ cells in SARS patients: relation to the acute lung injury and …
L He, Y Ding, Q Zhang, X Che, Y He, H Shen, H Wang, Z Li, L Zhao, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006
Recent advances in the detection of respiratory virus infection in humans
N Zhang, L Wang, X Deng, R Liang, M Su, C He, L Hu, Y Su, J Ren, F Yu, ...
Journal of medical virology 92 (4), 408-417, 2020
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
S Xia, L Yan, W Xu, AS Agrawal, A Algaissi, CTK Tseng, Q Wang, L Du, ...
Science advances 5 (4), eaav4580, 2019
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
S Jiang, L Du, Z Shi
Emerging microbes & infections 9 (1), 275-277, 2020
A distinct name is needed for the new coronavirus
S Jiang, Z Shi, Y Shu, J Song, GF Gao, W Tan, D Guo
The Lancet 395 (10228), 949, 2020
SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
X Wang, W Xu, G Hu, S Xia, Z Sun, Z Liu, Y Xie, R Zhang, S Jiang, L Lu
Cellular and Molecular Immunology, 1, 2020
The system can't perform the operation now. Try again later.
Articles 1–20